NEWARK, Del., August 5, 2026 — The global Gut Barrier & Digestive Health Supplement Market is projected to expand as consumers increasingly seek supplements linked to specific digestive health outcomes, validated ingredient evidence, and convenient finished-product formats. According to Future Market Insights (FMI), the market is expected to grow from USD 5.8 billion in 2026 to USD 12.6 billion by 2036, registering an 8.1% CAGR during the forecast period.

The market is benefiting from growing interest in gut-barrier health, established use of L-glutamine powders, increasing demand for strain-specific probiotic evidence, and flexible supplement formats. At the same time, restricted disease claims, variable clinical evidence, ingredient stability, shelf-life requirements, and country-specific regulatory pathways remain important considerations for manufacturers.

👉 Request Your Free Sample Report: Explore the detailed market forecast, segmentation, trends, and competitive insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-34312

Key Gut Barrier & Digestive Health Supplement Market Highlights

• Market Size (2026): USD 5.8 Billion
• Forecast Market Size (2036): USD 12.6 Billion
• Forecast Period: 2026–2036
• CAGR (2026–2036): 8.1%
• 2025 Market Value: USD 5.4 Billion
• Leading Ingredient: L-glutamine
• L-glutamine Share (2026): 34.5%
• Leading Application: Gut Barrier
• Gut Barrier Share (2026): 42.9%
• Leading Form: Powder
• Powder Share (2026): 43.4%
• Key Market Focus: Evidence-supported supplements targeting gut-barrier and digestive health outcomes
• Major Commercial Considerations: Ingredient validation, dosage evidence, strain identity, shelf-life stability, claim compliance, and country-specific registration

Analyst Viewpoint

Nandini Roy Choudhury, Principal Analyst at Future Market Insights, stated: “Gut-barrier supplements succeed through a direct match between the marketed ingredient and its studied dose across a protected finished format. L-glutamine powders require assay and flavor control across larger servings, while probiotic products require viable-cell counts tied to the labeled strain throughout shelf life. The strongest portfolios pair restrained digestive claims with country-specific registration plans and packaging that preserves the tested composition through routine storage."

Why Is the Gut Barrier & Digestive Health Supplement Market Growing?

The market is expanding as consumers and supplement manufacturers increasingly focus on specific digestive health endpoints rather than broad microbiome positioning. Products connecting named ingredients with measurable digestive outcomes are gaining commercial relevance as manufacturers seek clearer differentiation and stronger formulation evidence.

The market increased from USD 5.4 billion in 2025 to USD 5.8 billion in 2026 and is projected to reach USD 12.6 billion by 2036.

L-glutamine remains an important ingredient because of its established powder applications and flexible serving sizes. Probiotic formulations are also gaining attention as manufacturers increasingly emphasize strain-specific evidence, viable-cell counts, and stability through the product's shelf life.

The NIH Office of Dietary Supplements updated its probiotics fact sheet in March 2025, highlighting the importance of identifying the exact probiotic strain in clinical recommendations and advising consumers to consider CFU counts stated at the end of shelf life rather than only at manufacture.

These requirements are encouraging manufacturers to compete through verified strain identity, practical stability records, controlled formulations, and packaging designed to preserve product composition.

Key Growth Drivers

• Growing consumer interest in digestive health
• Increasing focus on gut-barrier health
• Rising demand for evidence-supported supplements
• Established use of L-glutamine powder formulations
• Flexible serving sizes for powdered ingredients
• Growing interest in strain-specific probiotic evidence
• Increasing attention to viable-cell counts throughout shelf life
• Rising demand for practical digestive health solutions
• Expansion of multi-ingredient supplement formulations
• Increasing importance of product stability and packaging protection

Key Segment Insights

Why Does L-Glutamine Lead the Ingredient Segment?

L-glutamine is projected to account for 34.5% of ingredient demand in 2026, supported by established powder use, flexible serving sizes, and its compatibility with digestive health supplement formulations.

Ingredient Highlights

• L-glutamine accounts for a 34.5% share in 2026.
• Established powder use supports commercial adoption.
• Flexible serving sizes provide formulation versatility.
• Larger servings require effective assay and flavor control.
• Ingredient consistency remains important for repeat production.
• L-glutamine can be incorporated into multi-ingredient formulations.
• Finished-product stability remains important during commercialization.

Other important ingredient categories include zinc carnosine, probiotics, fibers, and botanicals, with commercial positioning increasingly dependent on identity testing, dose evidence, and finished-product compatibility.

Why Does Gut Barrier Lead the Application Segment?

Gut Barrier is anticipated to account for 42.9% of application demand in 2026, reflecting growing interest in digestive products positioned around permeability, tight-junction, and related gut-barrier outcomes.

Application Highlights

• Gut Barrier accounts for 42.9% share in 2026.
• Growing interest in specific digestive endpoints supports demand.
• Manufacturers increasingly connect ingredients with measurable outcomes.
• Tight-junction and permeability-related positioning creates formulation opportunities.
• Restrained claims remain important in regulated markets.
• Evidence supporting the marketed dose can strengthen product positioning.
• Finished-product stability must preserve the tested composition.

The application landscape also includes digestion and immunity, with manufacturers increasingly evaluating products according to the specific endpoint supporting the marketed supplement claim.

Why Does Powder Lead the Form Segment?

Powder is forecast to represent 43.4% of form demand in 2026, supported by dose flexibility, compatibility with multi-ingredient blends, and practical shelf-life management.

Form Highlights

• Powder accounts for 43.4% share in 2026.
• Flexible serving sizes support formulation development.
• Powders are compatible with multi-ingredient blends.
• Larger servings require effective flavor management.
• Moisture control remains important during storage.
• Shelf-life protection supports consistent product performance.
• Packaging plays an important role in preserving tested composition.

Powder formulations are particularly relevant to L-glutamine products, where serving flexibility and established consumer familiarity support continued commercial adoption.

Regulatory and Regional Landscape

China and the United States represent distinct commercial pathways for digestive health supplements.

In China, health foods containing non-catalog ingredients may require registration through applicable regulatory routes. The SAMR service platform recorded 236 applications and 355 completed registrations or filings for qualifying health foods during August 2025, illustrating the importance of technical evidence and formal submission requirements for certain products.

In the United States, dietary supplements generally reach the market without finished-product premarket approval, but manufacturers remain subject to applicable ingredient declaration, labeling, and structure-function claim requirements. Brands therefore face compliance considerations across product labels, marketing communications, and distribution channels.

A practical commercialization strategy requires manufacturers to separate clinical substantiation from legal claim wording and channel-specific manufacturing documentation. Coordinating these workstreams can help reduce reformulation risks and support a clearer transition from pilot batches to repeat production.

👉 Get the PDF Brochure: Discover the report's core insights, forecast highlights, and research: https://www.futuremarketinsights.com/reports/brochure/rep-gb-34312

Regional Outlook

Regional commercialization varies according to consumer awareness, supplement regulations, clinical evidence requirements, labeling rules, and distribution infrastructure.

The United States remains an important market for dietary supplements, with manufacturers focusing on ingredient declarations, structure-function claims, product stability, and channel-specific compliance. Online and retail distribution provide broad access to consumers seeking digestive health products.

China represents an important market where applicable health food registration and filing pathways can influence commercialization, particularly for products containing non-catalog ingredients. Manufacturers must align technical evidence with the relevant submission route.

Germany, India, and the United Kingdom also provide opportunities as consumer interest in digestive health products expands, although manufacturers must adapt formulation, labeling, evidence, and claims strategies to each country's regulatory environment.

Overall, successful commercialization depends on combining validated ingredients, appropriate doses, protected finished formats, practical shelf-life controls, responsible claims, and country-specific regulatory planning.

Competitive Landscape

Competition continues to develop around ingredient validation, formulation expertise, strain-specific evidence, delivery protection, stability, regulatory support, and technical capabilities.

Key Companies Profiled

• Novonesis
• Kerry Group
• ADM
• Lallemand Health Solutions

• Seed Health
• Pendulum Therapeutics

• Probi AB
• BioGaia AB

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified and a recipient of the Stevie® Award) provides actionable market intelligence and consulting services across food & beverage, pharmaceuticals, chemicals, advanced materials, industrial manufacturing, sustainability, and consumer goods industries.

FMI delivers comprehensive market research, competitive intelligence, and strategic insights that help organizations identify emerging opportunities, evaluate market dynamics, and make informed business decisions across global markets.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.

For Sales: sales@futuremarketinsights.com
For Media: Rahul.singh@futuremarketinsights.com

For web: https://www.futuremarketinsights.com/